Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorBeijing Anzhen Hospital

About this trial

The study is a multicenter, three-arm, open-label, randomized, parallel-controlled trial, which plans to enroll 306 participants diagnosed with acute type A aortic dissection (ATAAD) from 7 hospitals in China. All patients receive total arch replacement (TAR) combined with frozen elephant trunk (FET) implantation and are randomized to Group 1 (arch-clamping technique under mild hypothermia), Group 2 (arch-clamping technique under moderate hypothermia) and Group 3 (Sun's procedure using bilateral antegrade cerebral perfusion) in the ratio of 1:1:1. After a 1-year follow-up, the validity and safety of the mild hypothermic arch-clamping technique for ATAAD was evaluated via the incidence of major adverse events including death, renal replacement therapy, stroke, and paraplegia, as well as times of circulatory arrest, cardiopulmonary bypass, and mechanical ventilation, and length of ICU stay.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aortic CTA confirmed as ATAAD according to the 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease;

Adult patients (18-70 years) weighing 50-120 kg;

Time interval between the onset of symptoms and operation is less than 14 days;

Indications for total aortic arch replacement are available;

Disqualifiers

History of chronic renal failure, hepatocirrhosis, and hepatic insufficiency;

Severe gastrointestinal complications of non-aortic dissection, such as mesenteric ischemia, gastrointestinal bleeding, hepatopancreaticobiliary dysfunction, and intestinal obstruction;

History of severe cerebral infarction (with cerebral infarction sequels);

Preoperative intubation or unconsciousness;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Arch-Clamping Technique under Mild Hypothermia

    Procedure/Surgery

    This procedure is performed under mild hypothermia. The branch arteries of the arch are reconstructed using the side arms of a Y-shaped graft, which allows bilateral antegrade cerebral perfusion (bACP) through the right axillary artery. A FET is deployed in the descending aorta and clamped together with the autologous aorta immediately, then distal perfusion is restored through the femoral artery. After the proximal procedures are completed, the distal anastomosis is performed in an end-to-end fashion. Finally, the main trunk of the Y-shaped graft is anastomosed to the proximal grafts.

  • Arch-Clamping Technique under Moderate Hypothermia

    Procedure/Surgery

    This procedure is performed under moderate hypothermia. The branch arteries of the arch are reconstructed using the side arms of a Y-shaped graft, which allow bACP through the right axillary artery. A FET is deployed in the descending aorta and clamped together with the autologous aorta immediately, then distal perfusion is restored through the femoral artery. After the proximal procedures are completed, the distal anastomosis is performed in an end-to-end fashion. Finally, the main trunk of the Y-shaped graft is anastomosed to the proximal grafts.

  • Total Arch Replacement combined Frozen Elephant Trunk Implantation using Bilateral Antegrade Cerebral Perfusion under Moderate Hypothermic Circulatory Arrest

    Procedure/Surgery

    This procedure is performed using bACP under MHCA, which involves FET deployment in the descending aorta followed by total arch replacement with a four-branched vascular graft. Deployment of the FET and suture of the distal anastomosis are completed during bACP. MHCA is terminated and distal reperfusion is initiated once the distal anastomosis is completed, and the left carotid artery is reconstructed first (after which bACP is stopped, rewarming is started and the brain is perfused bilaterally). The root or valve procedures and some concomitant operations, if indicated, are performed during the cooling phase.

Treatment groups

306 Participants
are divided into 3 treatment groups
Group A: Arch-clamping under mild hypothermiaExperimental treatment 1 intervention
Group B: Arch-clamping under moderate hypothermiaExperimental treatment 1 intervention
Group C: Sun's procedure using bACPActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Major adverse events

Major adverse events include death, renal replacement therapy, stroke, and paraplegia

Time frame
Thirty days and 12 months after the operation

Secondary outcomes

1

Circulatory arrest time

Time interval between ceasing and restarting cardiopulmonary bypass when core temperature reaches moderate hypothermia.

Time frame
During surgery
2

Cardiopulmonary bypass time

Start-to-end time of cardiopulmonary bypass to complete aortic repair.

Time frame
During surgery
3

Mechanical ventilation time

Time interval between mechanical ventilation and extubation after operation

Time frame
Discharge / 30 days after operation
4

The length of ICU stay

Time interval from ICU admission to transfer or death

Time frame
Discharge / 30 days after operation

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Beijing Anzhen Hospital

Lead sponsor

Yan'an Affiliated Hospital of Kunming Medical University

Collaborator

Xiangya Hospital of Central South University

Collaborator

West China Hospital

Collaborator

Guangzhou First People's Hospital

Collaborator

First Affiliated Hospital Xi'an Jiaotong University

Collaborator

Xijing Hospital,FMMU

Collaborator